An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study Christopher Cates Two recent reviews questioned the routine use of antibiotics in the initial management of acute otitis media.
1 2 My practice partners and I responded to the reviews by changing our policy, with the aim of reducing such prescribing in children. We measured the change one year after adopting the new policy.
Methods and results
From July 1997 my practice partners and I changed our policy on routine prescription of antibiotics in the initial management of acute otitis media in children. In children who were not particularly ill we gave the parents a handout that summarised the limited benefit of antibiotics on the basis of the data presented in the Cochrane review. 1 We advised parents to give regular paracetamol suspension; we also offered an antibiotic prescription but asked the parents to keep it for a day or two. They could redeem it at a pharmacy if the child did not got better over this period.
A local practice acted as a concurrent control. Both practices use amoxicillin suspension as the antibiotic of choice in children with acute otitis media, and, although the doctors in the control practice were aware of the new evidence, they did not use the handout or use deferred prescriptions. Monthly prescribing rates of all amoxicillin suspensions were obtained for each practice from the district health authority. The 12 months before July 1997 were used for baseline comparison, and the following 12 months were used to assess the impact of our change in policy. Both practices had closely similar list sizes (about 11 000 patients) throughout the study. As there was seasonal and annual variation in prescribing levels, monthly odds of prescriptions issued in relation to the national total were calculated for each practice; these were weighted and pooled by using the Mantel-Haenszel method.
3
Prescriptions for other antibiotic suspensions were also checked in our practice by comparing figures from the reports on level 3 prescribing analysis and cost data (PACT) with national figures, to check that other antibiotics were not being substituted for amoxicillin.
The table shows the monthly prescriptions for amoxycillin suspension for each practice, along with national totals. The median number of prescriptions per month in our practice fell from 75 to 47 after the change (median difference − 30.5 (95% confidence interval − 14 to − 31, 2P = 0.0065, Mann-Whitney U test). Compared with the national levels, the fall in prescribing amoxicillin suspension in our practice was − 32% ( − 25% to − 39%) and in the control practice was − 12% ( − 4% to − 20%).
Monthly totals of prescriptions for all amoxicillin suspensions for 12 months before (1996-7) and after % change from previous year (95% CI)* −32% (−39% to −25%) −12% (−20% to −4%) *Change in pooled odds ratios for the odds of prescriptions issued each month related to the national total for that month and compared with the odds for the same month in the previous year (the Mantel-Haenszel method was used to weight and pool the odds ratios). 1999;318:715-6 In the six months after the change in policy the number of antibiotic suspensions prescribed in our practice was 19% lower (16% to 21%) than in the same six months of the previous year. Over this period national prescribing of all antibiotic suspensions fell by 3%.
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Comment
Before my partners and I changed our policy, acute otitis media accounted for over half of all antibiotics prescribed for children in our practice. After our change in policy the proportion fell to a third, and as a consequence total antibiotic use for all infections in childhood fell by one fifth. As the evidence is not yet available to identify which children with acute otitis media benefit most from antibiotics we deferred prescriptions in those who were not systemically unwell (as suggested in the editorial comment accompanying one of the reviews in the BMJ 5 ). We found that most parents welcomed the written handout. The deferred prescription also acted as a safety net while they waited to see if the ear infection would resolve by itself and was often not redeemed. We are continuing with this policy, and in the current battle against antimicrobial resistance we would commend this approach to initial management of acute otitis media as a way of reducing the antibiotic load on children in the community.
A copy of the leaflet given to patients can be supplied by the author.
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Please, please me
Many words change their meaning with the years, and in some cases the new meaning is the opposite of the old, or at least at a tangent to it. A well known example is prestigious, which originally meant deceitful and now means esteemed. I am not sure, but I think that placebo may be in that camp.
The standard etymology is that placebo is the first person future indicative of the Latin word placeo, I please-that is, placebo = I shall please. But I don't think it's as simple as that.
The word first entered the English language through its erroneous use in a Latin translation of verse 9 of Psalm 116, which in Hebrew transliteration is "et'halekh liphnay adonai b'artzot hakhayim." This is correctly translated in the King James version as "I will walk before the Lord in the land of the living," but the Latin version in the Vulgate of St Jerome is "Placebo Domino in regione vivorum." This ("I shall please the Lord in the land of the living") is not a correct translation of the Hebrew, but perhaps Jerome reasoned that anyone who walked before (or as the Revised English Bible has it "in the presence of") the Lord would please Him, and used the word placebo for the sake of euphony or metre (the Latin line happens to be a dactylic pentameter, like the dactylic hexameters used in Greek and Latin epic verse, such as Virgil's Aeneid).
Because the verse was used in the Vespers of the Office for the Dead, the word placebo, with which it began, became in the thirteenth century the name of that service. And because some people attended the service and sang the Placebo, hoping to be rewarded by a dead person's relatives, the word came to mean a sycophant. As Chaucer wrote in The Parson's Tale: "Flatterers are the Devil's chaplains, always singing Placebo."
Then suddenly the word appeared in the "enlarged and improved" second edition of George Motherby's New Medical Dictionary of 1785 (not having appeared in the first edition of 1775), where it was defined as "a common place method or medicine." Why placebo came to have that meaning at that time is not clear. Common-place (usually spelt with a hyphen in those days) meant then, as it does now, ordinary, unoriginal, trivial, and so Motherby's definition suggests neither the modern meaning of placebo nor its traditional derivation ("I shall please"). However, the word "placere" also meant "to be popular," so a placebo may originally have been a drug that was of sufficient efficacy, or perceived efficacy, to be popular.
The word next appears in 1811 in Hooper's Medical Dictionary: "any medicine adapted more to please than benefit the patient." This sounds closer to our modern use of the word, and it is possible that a change in meaning may have taken place at about the turn of the nineteenth century, perhaps through a misunderstanding over the original derivation; or perhaps through a form of medical snobbery, the assumption being that anything popular couldn't be of much value; or possibly harking back to the old idea of sycophancy-that is, a medicine that flattered the user into believing it to be effective.
So perhaps from being a popular medicine with a useful if minor effect, a placebo became a medicine without any effect at all, or not one that you could rely on. More medical examples of the use of the word before 1785 or at around the turn of the nineteenth century might throw some light on the matter.
Jeff Aronson, clinical pharmacologist, Oxford
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